Quick Answer
Ingevity Corp reported R&D Expense of $28.40 million for fiscal year 2025.
Ingevity Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $28.40M | +15.9% |
| 2024 | $24.50M | -3.5% |
| 2023 | $25.40M | -16.2% |
| 2022 | $30.30M | +15.2% |
| 2021 | $26.30M | +16.4% |
| 2020 | $22.60M | +14.7% |
| 2019 | $19.70M | -8.4% |
| 2018 | $21.50M | +8.6% |
| 2017 | $19.80M | +12.5% |
| 2016 | $17.60M | +1.1% |
| 2015 | $17.40M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.00M | +12.9% | -10.3% |
| June 30, 2025 | $7.80M | +6.8% | +1.3% |
| March 31, 2025 | $7.70M | +13.2% | +24.2% |
| September 30, 2024 | $6.20M | -20.5% | -15.1% |
| June 30, 2024 | $7.30M | -8.8% | +7.4% |
| March 31, 2024 | $6.80M | -22.7% | -12.8% |
| September 30, 2023 | $7.80M | +2.6% | -2.5% |
| June 30, 2023 | $8.00M | -2.4% | -9.1% |
- Ingevity Corp showed an increase of +15.9% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, Ingevity Corp’s r&d expense has grown by 63.2% (from $17.40 million to $28.40 million).
- The most recent figure is from Ingevity Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: